| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 12/17/2008 | CN101322683A Gel for eye containing bromfenac sodium hydrate and preparation thereof |
| 12/17/2008 | CN101322607A Chinese tea health-care pillow |
| 12/17/2008 | CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 12/16/2008 | US7465815 Cannabinoid receptor modulator |
| 12/16/2008 | US7465737 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 12/16/2008 | US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 12/16/2008 | US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 12/16/2008 | US7465723 Use of carboxamides for the treatment of tinnitus |
| 12/16/2008 | US7465463 Topical applying; vision defects |
| 12/16/2008 | US7465458 In situ administering Clostridium toxin; antiinflammatory agents |
| 12/11/2008 | WO2008150954A1 Treatment of age-related macular degeneration |
| 12/11/2008 | WO2008148564A1 Neramexane for the treatment of nystagmus |
| 12/11/2008 | WO2008148292A1 An ophthalmic, otic or nasal composition and its use |
| 12/11/2008 | WO2008124009A3 Treating glaucoma |
| 12/11/2008 | WO2008113863A3 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
| 12/11/2008 | WO2008028032A3 Therapeutic substituted hydantoins and related compounds |
| 12/11/2008 | WO2005046562A3 Use of sulfated hyaluronic acid |
| 12/11/2008 | US20080306163 such as conjunctivitis via administering (+)-3-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one; phosphodiesterase inhibitors; for topical administration and for use as drops |
| 12/11/2008 | US20080306160 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 12/11/2008 | US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione |
| 12/11/2008 | US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 12/11/2008 | US20080306093 Modulation of chemosensory receptors and ligands associated therewith |
| 12/11/2008 | US20080306085 Non-imidazole aryloxyalkylamines |
| 12/11/2008 | US20080306076 Modulation of chemosensory receptors and ligands associated therewith |
| 12/11/2008 | US20080306065 Metalloproteinase Inhibitors |
| 12/11/2008 | US20080306038 Compositions and Methods for Modulating Inflammation Using Fluoroquinolones |
| 12/11/2008 | US20080306022 Agent for Applying to Mucosa and Method for the Production Thereof |
| 12/11/2008 | US20080306012 Polysaccharide-Derived Nitric Oxide-Releasing Carbon-Bound Diazeniumdiolates |
| 12/11/2008 | US20080306011 Method of Controlling the Proliferation of Vascular Endothelial Cells and Inhibiting Lumen Formation |
| 12/11/2008 | US20080305994 Pharmaceutical Compositions and Method for Treating, Reducing, Ameliorating, Alleviating, or Preventing Dry Eye |
| 12/11/2008 | US20080305990 Method of Producing Fully Carbamylated Erythropoietin |
| 12/11/2008 | US20080305172 Ophthalmic depot formulations for periocular or suconjunctival administration |
| 12/11/2008 | US20080305106 Novel Gene Disruptions, Composition and Methods Relating Thereto |
| 12/11/2008 | US20080305103 Intraocular pressure-regulated early genes and uses thereof |
| 12/11/2008 | US20080305083 Gfap-based gene therapy for treatment of retinal diseases |
| 12/11/2008 | US20080305046 Molecular imaging methods for diagnosis and evaluation of ocular and systemic diseases |
| 12/11/2008 | CA2688439A1 Treatment of age-related macular degeneration |
| 12/11/2008 | CA2682326A1 Neramexane for the treatment of nystagmus |
| 12/10/2008 | EP2000483A2 Vegf receptor fusion protein and use thereof |
| 12/10/2008 | EP2000469A2 Acylaminopiperidine compound |
| 12/10/2008 | EP1475382B1 Compounds as semaphorin inhibitors |
| 12/10/2008 | EP1391199B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 12/10/2008 | CN101321742A Compositions and methods of treating retinal disease |
| 12/10/2008 | CN101317948A Preparation method for Chinese medicine for preventing and controlling myopic eye |
| 12/10/2008 | CN101317921A Externally washing medicament for treating external hordeolum |
| 12/10/2008 | CN101317898A Night plaster medicine for concurrent eye diseases of diabetes |
| 12/10/2008 | CN101317847A Medicament composition for eyes or nose, and uses thereof |
| 12/10/2008 | CN100441594C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 12/10/2008 | CN100441581C 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1,2-a]pyrimidin-5(1H)-one derivatives |
| 12/10/2008 | CN100441192C Use of mometasone furoate for treating airway nassage and lung diseases |
| 12/10/2008 | CN100441169C Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 12/09/2008 | US7462635 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia |
| 12/09/2008 | US7462621 9-[3-(2-Fluorophenyl)-propyl]-7,7-dimethyl-2-(pyridin-4-yl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; neurodegenerative disease caused by abnormal activity of GSK3 beta (glycogen synthase kinase beta 3) or GSK3 beta and cdk5/p253 |
| 12/09/2008 | US7462606 Antiseptics; surgery; controlling release of drugs |
| 12/09/2008 | US7462370 Purified bilberry extract containing a mixture of glycosides of delphinidin, cyanidin, petunidin, peonidin, and malvidin; no added bisulfite ions; nutraceuticals and pharmaceuticals |
| 12/09/2008 | US7462353 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis |
| 12/09/2008 | CA2388142C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 12/09/2008 | CA2250188C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 12/04/2008 | WO2008147883A1 Prevention and treatment of complement-associated eye conditions |
| 12/04/2008 | WO2008146871A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
| 12/04/2008 | WO2008146721A1 Prophylactic or therapeutic agent for age-related macular degeneration |
| 12/04/2008 | WO2008145064A1 The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof |
| 12/04/2008 | WO2008079697A3 Method of treating mucin deficiency with an active pharmaceutical and related composition |
| 12/04/2008 | WO2008029276A3 Compositions and methods for the treatment of ophthalmic disease |
| 12/04/2008 | US20080300292 Nitrosated and Nitrosylated Compounds, Compositions and Methods for the Treatment of Ophthalmic Disorders |
| 12/04/2008 | US20080300277 Process to improve stability of a pharmaceutical composition |
| 12/04/2008 | US20080300269 Glaucoma; prostaglandin receptor modulators; cyclopentyl compounds such as 5-{3-[(1S,5S)-5-(3-Chloro-5-hydroxymethyl-phenoxymethyl)-4-oxo-cyclopent-2-enyl]-propyl}-thiophene-2-carboxylic acid |
| 12/04/2008 | US20080300238 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 12/04/2008 | US20080300182 Eye disease treating agent and method for treating eye disease |
| 12/04/2008 | US20080299178 Sustained release intraocular implants and methods for preventing retinal dysfunction |
| 12/04/2008 | US20080299176 Drug delivery device comprising crosslinked polyurethane-siloxane-containing copolymers |
| 12/04/2008 | US20080299134 Recombinant Anti-Interleukin-9 Antibodies |
| 12/04/2008 | US20080299130 Methods And Compositions For The Treatment Of Ocular Neovascularization |
| 12/04/2008 | US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof |
| 12/04/2008 | CA2687948A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity |
| 12/04/2008 | CA2686560A1 Prophylactic or therapeutic agent for age-related macular degeneration |
| 12/04/2008 | CA2683498A1 Prevention and treatment of complement-associated eye conditions |
| 12/03/2008 | EP1997804A1 Mmp-13-selective inhibitor |
| 12/03/2008 | EP1997513A1 Photodynamic therapy for treating conditions of the eye |
| 12/03/2008 | EP1997501A2 Extracts from Ajuga reptans cell lines, their preparation and use |
| 12/03/2008 | EP1996546A2 Substituted gamma lactams as prostaglandin ep2 agonists |
| 12/03/2008 | EP1996195A2 Hydroxylamines and derivatives for the inhibition of complement activation |
| 12/03/2008 | EP1827373B1 Ophthalmic emulsions containing prostaglandins |
| 12/03/2008 | EP1818059B1 Preventive or therapeutic agent for glaucoma |
| 12/03/2008 | EP1511499B1 Immunomodulatory compounds and methods of use thereof |
| 12/03/2008 | EP1383787B1 Sapogenin derivatives, their synthesis and use |
| 12/03/2008 | EP1377540B1 Inhibitors of integrin alpha-v-beta-6 |
| 12/03/2008 | CN101316853A Oxazolopyridine derivatives as SIRTUIN modulators |
| 12/03/2008 | CN101316600A Composition having effect on treatment and prevention of dry eye syndrome |
| 12/03/2008 | CN101316584A Pharmaceutical for prevention and treatment of ophthalmic disease induced by increase in vasopermeability |
| 12/03/2008 | CN101313982A Traditional Chinese medicine onion slurry, preparing method and uses thereof |
| 12/03/2008 | CN101313957A Capsule for treating retina vein occlusion |
| 12/03/2008 | CN101313956A Compound chrysanthemum capsule |
| 12/03/2008 | CN101313946A Traditional Chinese medicine capsule for treating cataract |
| 12/03/2008 | CN101313899A Medicament composition for eyes containing sodium bromfenac |
| 12/03/2008 | CN100439493C Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 12/03/2008 | CN100439399C Human antibodies that bind human IL-12 and methods for producing |
| 12/03/2008 | CN100439396C Polypeptide of ramification of ciliary nerves nutrilite for curing obesity |
| 12/03/2008 | CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
| 12/03/2008 | CN100438906C The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy |